Literature DB >> 12776187

VEGF receptor expression and signaling in human bladder tumors.

Weicheng Wu1, Xiaodong Shu, Harut Hovsepyan, Raymond D Mosteller, Daniel Broek.   

Abstract

Overexpression of vascular endothelial growth factor receptors (VEGFRs) has been reported in a variety of tumor types. Here we find that 11 out of the 14 bladder tumor cell lines examined express one or more VEGF receptors. Analysis of the T24 bladder tumor cell line reveals a functional autocrine loop involving VEGF and the Flk-1 receptor. Blocking VEGF expression in T24 cells results in a decrease in DNA synthesis. The Flk-1 receptor in T24 cells is phosphorylated in response to VEGF-121 or VEGF-165, and an Flk-1 inhibitor blocks VEGF to ERK signaling. We report that VEGF stimulation of T24 cells results in activation of H- and N-Ras and this is dependent on cellular sphingosine kinase 1 (SPK1) activity. Previously, we found VEGF-induced activation of Ras appears to be independent of a Ras-guanine nucleotide exchange factors (GEFs). Here we report that sphingosine can stimulate Ras-GTPase activating protein (GAP) activity in vitro, and sphingosine-1-phosphate (SPP) can block the stimulatory effects of sphingosine. We present a model where the balance between sphingosine and SPP regulates Ras-GAP activity such that stimulation of SPK1 favors downregulation of Ras-GAP and thereby the activation of Ras proteins. These data highlight a VEGF pathway that may be involved in the survival and proliferation of bladder tumor cells as well as other tumor cell types.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776187     DOI: 10.1038/sj.onc.1206285

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

Review 1.  Targeted therapies in urothelial carcinoma.

Authors:  Monalisa Ghosh; Sam J Brancato; Piyush K Agarwal; Andrea B Apolo
Journal:  Curr Opin Oncol       Date:  2014-05       Impact factor: 3.645

Review 2.  Regulation and functional roles of sphingosine kinases.

Authors:  Regina Alemany; Chris J van Koppen; Kerstin Danneberg; Michael Ter Braak; Dagmar Meyer Zu Heringdorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-23       Impact factor: 3.000

Review 3.  Targeting angiogenesis in bladder cancer.

Authors:  Aymen A Elfiky; Jonathan E Rosenberg
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

4.  Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases.

Authors:  Lynn W Maines; Kevin J French; Ellen B Wolpert; David A Antonetti; Charles D Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

5.  Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase.

Authors:  Alexander A Chumanevich; Deepak Poudyal; Xiangli Cui; Tia Davis; Patricia A Wood; Charles D Smith; Lorne J Hofseth
Journal:  Carcinogenesis       Date:  2010-08-05       Impact factor: 4.944

Review 6.  Current chemotherapeutic strategies against bladder cancer.

Authors:  Yozo Mitsui; Hiroaki Yasumoto; Naoko Arichi; Satoshi Honda; Hiroaki Shiina; Mikio Igawa
Journal:  Int Urol Nephrol       Date:  2011-06-12       Impact factor: 2.370

7.  Sphingosine kinase protects lipopolysaccharide-activated macrophages from apoptosis.

Authors:  Weicheng Wu; Raymond D Mosteller; Daniel Broek
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.

Authors:  Arjun V Balar; Andrea B Apolo; Irina Ostrovnaya; Svetlana Mironov; Alexia Iasonos; Alisa Trout; Ashley M Regazzi; Ilana R Garcia-Grossman; David J Gallagher; Matthew I Milowsky; Dean F Bajorin
Journal:  J Clin Oncol       Date:  2013-01-22       Impact factor: 44.544

9.  Phase II Study of Pazopanib and Paclitaxel in Patients With Refractory Urothelial Cancer.

Authors:  Sujata Narayanan; Anthony Lam; Ulka Vaishampayan; Lauren Harshman; Alice Fan; Russell Pachynski; Shermeen Poushnejad; Denise Haas; Shufeng Li; Sandy Srinivas
Journal:  Clin Genitourin Cancer       Date:  2016-03-12       Impact factor: 2.872

10.  The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma.

Authors:  Hao Yu; Shiqian Zhang; Renhua Zhang; Linlin Zhang
Journal:  J Exp Clin Cancer Res       Date:  2009-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.